Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2010
04/15/2010US20100093785 Diamine derivatives
04/15/2010US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/15/2010US20100093757 Therapeutic agents 414
04/15/2010US20100093748 Substituted piperidines having protein kinase inhibiting activity
04/15/2010US20100093746 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of cns diseases
04/15/2010US20100093741 Certain chemical entities, compositions and methods
04/15/2010US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
04/15/2010US20100093720 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
04/15/2010US20100093719 Pharmacokinetically improved compounds
04/15/2010US20100093718 Compounds
04/15/2010US20100093696 2-amino pyrimidine compounds
04/15/2010US20100093695 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors
04/15/2010US20100093689 Heteroaryl compounds as p2y1 receptor inhibitors
04/15/2010US20100093688 Porphyrin catalysts and methods of use thereof
04/15/2010US20100089285 Colorant compound and ink including the colorant compound
04/15/2010CA2755968A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
04/15/2010CA2739782A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors
04/15/2010CA2739776A1 Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
04/15/2010CA2739373A1 Tricyclic oxazolidinone antibiotic compounds
04/15/2010CA2738814A1 Hiv integrase inhibitors
04/15/2010CA2736097A1 Carbazole compounds and therapeutic uses of the compounds
04/14/2010EP2173752A2 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrroloý2,3-d¨pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
04/14/2010EP2173751A2 Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3- cyclopentylpropanenitrile
04/14/2010EP2173748A2 Indolyl pyrrolidines for the treatment of cancer
04/14/2010EP2173747A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
04/14/2010EP2173734A2 Chemical compounds
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1477482B1 Novel phenylalanine derivative
04/14/2010EP1294922B1 Treating cancer using organelle crystallizing agents
04/14/2010CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof
04/14/2010CN101279989B Preparation of high-photoelectric transformation efficiency manganese phthalocyanine bisphenol-A epoxy derivates
04/13/2010US7696222 Indole derivatives as CRTH2 receptor antagonists
04/13/2010US7696213 2-amino-8-(trans-4-hydroxycyclohexyl)-4-methyl-7-oxo-N-1H-pyrazol-5-yl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide; anticarcinogenic; phosphoinositide 3-kinase alpha (PI3-K alpha ) inhibitor; cell cycle regulation, proliferation, apoptosis; inhibit resistance to cytotoxic agents in cancer cells
04/13/2010US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/13/2010US7695643 Long wavelength shifted benzotriazole UV-absorbers and their use
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2430363C Compounds and their uses
04/13/2010CA2425440C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2345809C 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
04/08/2010WO2010039947A1 Novel compounds as calcium channel blockers
04/08/2010WO2010039825A2 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
04/08/2010WO2010039793A1 Hepatitis c virus inhibitors
04/08/2010WO2010039678A1 Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes
04/08/2010WO2010039187A2 Fused diimidazodiazepine compounds and methods of use and manufacture thereof
04/08/2010WO2010038060A1 Heterocyclic jak kinase inhibitors
04/08/2010WO2010037339A1 Aminoquinazoline derivatives and their salts with antineoplastic activity
04/08/2010WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010WO2010007318A3 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
04/08/2010WO2010007248A3 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
04/08/2010WO2009117482A8 Mtor inhibitor salt forms
04/08/2010WO2009115084A3 Pyrrolopyrimidine derivatives, and use thereof
04/08/2010US20100087640 Method for production of aryl-substituted annelated pyrimidines
04/08/2010US20100087467 Compositions Useful As Inhibitors of Protein Kinases
04/08/2010US20100087452 Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process
04/08/2010US20100087451 Polymorph b of n--n-methyl-acetamide
04/08/2010US20100087419 Hiv integrase inhibitors
04/08/2010US20100087320 Arylphenyl-substituted cyclic keto-enols
04/08/2010US20100086482 Divergent synthesis of looped poly(ester)-and poly(ether)-substituted dendrons and dendrimers
04/08/2010CA2739422A1 Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes
04/08/2010CA2738650A1 Fused diimidazodiazepine compounds and methods of use and manufacture thereof
04/08/2010CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010CA2737480A1 Novel compounds as calcium channel blockers
04/08/2010CA2737217A1 Heterocyclic jak kinase inhibitors
04/07/2010EP2170998A1 Phthalocyanine salts suitable for use in offset inks
04/07/2010EP2170896A2 Polycyclic guanine derivatives and use thereof
04/07/2010EP2170895A1 Sildenafil n-oxide as prodrug
04/07/2010EP2170894A1 Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline
04/07/2010EP2170893A1 Heterocyclic compounds and use thereof as erk inhibitors
04/07/2010EP2170892A2 Imidazopyrazines as protein kinase inhibitors
04/07/2010EP2170891A1 Pyrazolopyrimidinone kinase inhibitor
04/07/2010EP2170890A2 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
04/07/2010EP2170887A2 Heterocyclic compounds as raf kinase modulators
04/07/2010EP2170886A1 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors
04/07/2010EP2170836A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
04/07/2010EP2170827A2 Indolin-2-ones and aza-indolin-2-ones
04/07/2010EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
04/07/2010EP2170350A2 Substituted imidazoheterocycles
04/07/2010EP2170260A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
04/07/2010EP2170073A1 Selective inhibitors for cyclin-dependent kinases
04/07/2010EP2170065A1 Diphenyl substituted alkanes
04/07/2010EP1987010B1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
04/07/2010EP1934214B1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/07/2010CN1872854B Antibiotic in lactam class, and prepartion method
04/07/2010CN101691374A Pretreatment process for microalgae
04/07/2010CN101691373A Medicament for treating erectile dysfunction and premature ejaculation and preparation thereof
04/07/2010CN101691372A Aildenafil citrate crystal form C and preparation method and application thereof
04/07/2010CN101691371A Pemetrexed thiocarbamide salt and preparation method thereof
04/07/2010CN101691370A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
04/06/2010US7692026 Pyrrolotriazole compound
04/06/2010US7692002 to coordinate vitamin B12 through its cyanide to a metal to form a [Co]-CN-M complex, wherein [Co] represents vitamin B12 without cyanide; such vitamin B12 derivatives are chemically stable and can be easily produced; e.g. use of precursor complex cis-diamminedichloroplatinum(II)
04/06/2010US7691892 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
04/06/2010US7691868 N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases
04/06/2010US7691865 4-(2-pyridin-2-yl-pyrazolo[1,5-a]pyridin-3-yl)-pyrimidin-2-ylamine; 4-[2-(6-methyl-pyridin-2-yl)-pyrazolo[1,5-a]pyrimidin-3-yl]-pyrimidin-2-ylamine; high affinity for Alk 5 and/or Alk 4 hence useful as antagonists thereof; fibrotic disorders
04/06/2010US7691864 Anti-hypertensive composition and methods of treatment
04/06/2010US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes
04/06/2010US7691859 prenyl transferase inhibitors; e.g. 8-butyl-7-(3-(imidazol-5-yl)-1-oxopropyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine; antitumor agents; cancer of breast, colon, pancreas, prostate, lung, ovarian, epidermal; hematopoietics; Ras-dependent tumor;
04/06/2010US7691857 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors